[1]
Naqvi A.A.T., Fatima K., Mohammad T. et al.: Insights into SARS-CoV-2
genome, structure, evolution, pathogenesis and therapies: Structural
genomics approach. Biochim Biophys Acta Mol Basis Dis 2020; 1866:
165878.
[2]
Holshue M.L., DeBolt C., Lindquist S. et al.: First Case of 2019 Novel
Coronavirus in the United States. N Engl J Med 2020; 382: 929-936.
[3]
Chen Y., Li L.: SARS-CoV-2: virus dynamics and host response. Lancet
Infect Dis 2020; 20: 515-516.
[4]
Rod J.E., Oviedo-Trespalacios O., Cortes-Ramirez J.: A brief-review of the
risk factors for covid-19 severity. Rev Saude Publica 2020; 54: 60.
[5]
Bulut C., Kato Y.: Epidemiology of COVID-19. Turk J Med Sci 2020; 50:
563-570.
[6]
Groban L., Wang H., Sun X. et al.: Is Sex a Determinant of COVID-19
Infection? Truth or Myth? Curr Hypertens Rep 2020; 22: 62.
[7]
Comunian S., Dongo D., Milani C. et al.: Air Pollution and Covid-19: The Role
of Particulate Matter in the Spread and Increase of Covid-19’s Morbidity
and Mortality. Int J Environ Res Public Health 2020; 17: 4487.
[8]
Webb Hooper M., Nápoles A.M., Pérez-Stable E.J.: COVID-19 and Racial/
Ethnic Disparities. JAMA 2020; 323: 2466–2467.
[9]
Moriguchi T., Harii N., Goto J. et al.: A first case of meningitis/encephalitis
associated with SARS-Coronavirus-2. Int J Infect Dis 2020; 94: 55-58.
[10]
Abdennour L., Zeghal C., Dème M. et al.: Interaction brain-lungs. Ann Fr
Anesth Reanim 2012; 31: 101-107.
[11]
Bohmwald K., Gálvez N.M.S., Ríos M. et al.: Neurologic Alterations Due to
Respiratory Virus Infections. Front Cell Neurosci 2018; 12: 386.
[12]
Unni S.K., Růžek D., Chhatbar C. et al.: Japanese encephalitis virus: from
genome to infectome. Microbes Infect 2011; 13: 312-321.
[13]
Turner A.J., Hiscox J.A., Hooper N.M.: ACE2: from vasopeptidase to
SARS virus receptor. Trends Pharmacol Sci 2004; 25: 291-294.
[14]
Chen R., Wang K., Yu J. et al: The Spatial and Cell-Type Distribution of
SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front.
Neurol. 2021; 11: 573095
[15]
Desforges M., Le Coupanec A., Dubeau P. et al.: Human Coronaviruses
and Other Respiratory Viruses: Underestimated Opportunistic Pathogens
of the Central Nervous System? Viruses 2019; 12: 14.
[16]
Mori I.: Transolfactory neuroinvasion by viruses threatens the human
brain. Acta Virol 2015; 59: 338-349.
[17]
Niazkar H.R., Zibaee B., Nasimi A. et al.: The neurological manifestations
of COVID-19: a review article. Neurol Sci 2020; 41: 1667-1671.
[18]
Lippi G., Mattiuzzi C., Bovo C. et al.: Headache is an important symptom
in patients with coronavirus disease 2019 (COVID-19). Diagnosis (Berl)
2020; 7: 409-411.
[19]
Garg R.K.: Spectrum of Neurological Manifestations in Covid-19:
A Review. Neurol India 2020; 68: 560-572.
[20]
Panda P.K., Sharawat I.K., Panda P. et al.: Neurological Complications
of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-
Analysis. J Trop Pediatr 2020. doi:10.1093/tropej/fmaa070
[21]
Stafstrom C.E., Jantzie L.L.: COVID-19: Neurological Considerations in
Neonates and Children. Children 2020; 7: 133.
[22]
Chen T.H.: Neurological involvement associated with COVID-19 infection
in children. J Neurol Sci 2020; 418: 117096.
[23]
Jeng M.J.: Coronavirus disease 2019 in children: Current status. J Chin
Med Assoc 2020; 83: 527-533.
[24]
Khalifa M., Zakaria F., Ragab Y. et al.: Guillain-Barré Syndrome Associated
With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and
Coronavirus Disease 2019 in a Child. J Pediatric Infect Dis Soc 2020; 9:
510–513.
[25]
Hasan I., Saif-Ur-Rahman K., Hayat S. et al.: Guillain-Barré syndrome
associated with SARS-CoV-2 infection: A systematic review and
individual participant data meta-analysis. J Peripher Nerv Syst 2020; 25:
335-343.
[26]
Rahimi K.: Guillain-Barre syndrome during COVID-19 pandemic: an
overview of the reports Neurol Sci 2020; 41: 3149-3156.
[27]
Frank C.H.M., Almeida T.V.R., Marques E.A. et al.: Guillain-Barré
Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient.
J Trop Pediatr 2020. doi:10.1093/tropej/fmaa044
[28]
Paybast S., Gorji R., Mavandadi S.: Guillain-Barré Syndrome as
a Neurological Complication of Novel COVID-19 Infection: A Case Report
and Review of the Literature. Neurologist 2020;25:101-103.
[29]
Uncini A., Vallat J., Jacobs B.C.: Guillain-Barré syndrome in SARS-
CoV-2 infection: an instant systematic review of the first six months of
pandemic. J Neurol Neurosurg Psychiatry 2020;91:1105-1110.
[30]
Cetinkaya E.A.: Coincidence of COVID-19 Infection and Smell-Taste
Perception Disorders. J Craniofac Surg 2020; 31: 625-626.
[31]
Lima M.A., Silva M.T.T., Oliveira R.V. et al.: Smell dysfunction in COVID-19
patients: More than a yes-no question. J Neurol Sci 2020; 418: 117107.
[32]
Sharifian-Dorche M., Huot P., Osherov M. et al.: Neurological complications
of coronavirus infection; a comparative review and lessons learned
during the COVID-19 pandemic. J Neurol Sci 2020; 417: 117085.
[33]
Qiu C., Cui C., Hautefort C. et al.: Olfactory and Gustatory Dysfunction as
an Early Identifier of COVID-19 in Adults and Children: An International
Multicenter Study. Otolaryngol Head Neck Surg 2020; 163: 714-721.
[34]
DeBiasi R.L., Song X., Delaney M. et al.: Severe Coronavirus Disease-2019
in Children and Young Adults in the Washington, DC, Metropolitan
Region. J Pediatr 2020; 223: 199-203.
[35]
Concheiro-Guisan A., Fiel-Ozores A., Novoa-Carballal R. et al.: Subtle
olfactory dysfunction after SARS-CoV-2 virus infection in children. Int J
Pediatr Otorhinolaryngol 2020; 140: 110539.
[36]
Mak P.Q., Chung K.S., Wong J.S. et al.: Anosmia and Ageusia: Not
an Uncommon Presentation of COVID-19 Infection in Children and
Adolescents. Pediatr Infect Dis J 2020; 39: 199-200.
[37]
Maniaci A., Iannella G., Vicini C. et al.: A Case of COVID-19 with Late-
Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy.
Am J Case Rep 2020; 21: 925813-1–925813-6.
[38]
Hatipoglu N., Yazici Z.M., Palabiyik F. et al.: Olfactory bulb magnetic
resonance imaging in SARS-CoV-2-induced anosmia in pediatric cases.
Int J Pediatr Otorhinolaryngol 2020; 139: 110469.
[39]
Marhaeni W., Wijaya A.B., Kusumaningtyas P. et al.: Thalassemic Child
Presenting with Anosmia due to COVID-19. Indian J Pediatr 2020; 87: 750.
[40]
Kasuga Y., Nishimura K., Go H. et al.: Severe olfactory and gustatory
dysfunctions in a Japanese pediatric patient with coronavirus disease
(COVID-19). J Infect Chemother 2021; 27: 110-112.
[41]
Ferraro S., Tuccori M., Convertino I. et al.: Olfactory and gustatory
impairments in COVID-19 patients: Role in early diagnosis and
interferences by concomitant drugs. Br J Clin Pharmacol 2020.
doi:10.1111/bcp.14634
[42]
Podemski R.: Kompendium neurologii. VIA Medica, Gdańsk 2014
[43]
Oualha M., Bendavid M., Berteloot L.,et al.: Severe and fatal forms of
COVID-19 in children. Arch Pediatr 2020; 27: 235-238.
[44]
Kest H., Kaushik A., DeBruin W. et al.: Multisystem Inflammatory
Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus
(SARS-CoV-2) Infection. Case Rep Pediatr 2020; 2020: 8875987.
[45]
Freij B.J., Gebara B.M., Tariq R. et al.: Fatal central nervous system co-
infection with SARS-CoV-2 and tuberculosis in a healthy child. BMC
Pediatr 2020; 20: 429.
[46]
Kaur H., Mason J.A., Bajracharya M. et al.: Transverse Myelitis in a Child
With COVID-19. Pediatr Neurol 2020; 112: 5-6.
[47]
Yousefi K., Poorbarat S., Abasi Z. et al.: Viral meningitis associated with
covid-19 in a 9-year-old child: a case report. Pediatr Infect Dis J 2021;
40: 87-98.
[48]
Ellul M.A., Benjamin L., Singh B. et al.: Neurological associations of
COVID-19. Lancet Neurol 2020; 19: 767-783.
[49]
Ye M., Ren Y., Lv T.: Encephalitis as a clinical manifestation of COVID-19.
Brain Behav Immun 2020; 88: 945-946.
[50]
Conto-Palomino N.M., Cabrera-Bueno M.L., Vargas-Ponce K.G. et al.:
Encephalitis associated with COVID-19 in a 13-year-old girl: A case
report. Medwave 2020; 20: 7984.
[51]
McAbee G.N., Brosgol Y., Pavlakis S. et al.: Encephalitis Associated with
COVID-19 Infection in an 11-Year-Old Child. Pediatr Neurol 2020; 109: 94.
[52]
de Miranda Henriques-Souza A.M., de Melo A.C.M.G., de Aguiar Coelho
Silva Madeiro B. et al.: Acute disseminated encephalomyelitis in
a COVID-19 pediatric patient. Neuroradiology 2020; 1-5.
[53]
Qi X., Keith K.A., Huang J.H.: COVID-19 and stroke: A review. Brain
Hemorrhages 2020. doi:10.1016/j.hest.2020.11.001
[54]
Fullerton H.J., Elkind M.S., Barkovich A.J. et al.: The vascular effects
of infection in Pediatric Stroke (VIPS) Study. J Child Neurol 2011; 26:
1101-1110.
[55]
Mirzaee S.M.M., Gonçalves F.G., Mohammadifard M. et al.: Focal Cerebral
Arteriopathy in a Pediatric Patient with COVID-19. Radiology 2020; 297:
274-275.
[56]
Gulko E., Overby P., Ali S. et al.: Vessel Wall Enhancement and Focal
Cerebral Arteriopathy in a Pediatric Patient with Acute Infarct and
COVID-19 Infection. AJNR Am J Neuroradiol 2020; 41: 2348-2350.
[57]
Kihira S., Morgenstern P.F., Raynes H. et al.: Fatal cerebral infarct in a child
with COVID-19. Pediatr Radiol 2020; 50: 1479-1480.
[58]
Dakay K., Cooper J., Bloomfield J. et al.: Cerebral Venous Sinus
Thrombosis in COVID-19 Infection: A Case Series and Review of The
Literature. J Stroke Cerebrovasc Dis 2021;30.
[59]
Savić D., Alsheikh T.M., Alhaj A.K. et al.: Ruptured cerebral
pseudoaneurysm in an adolescent as an early onset of COVID-19
infection: case report. Acta Neurochir 2020; 162: 2725-2729.
[60]
Beslow L.A., Linds A.B., Fox C.K. et al.: Pediatric Ischemic Stroke: An
Infrequent Complication of SARS-CoV-2. Ann Neurol 2020. doi:10.1002/
ana.25991
[61]
Muhammad S., Petridis A., Cornelius JF. et al..: Letter to editor: Severe
brain haemorrhage and concomitant COVID-19 Infection: A neurovascular
complication of COVID-19. Brain Behav Immun. 2020; 87: 150-151.
[62]
Leung A.K., Hon K.L., Leung T.N.: Febrile seizures: an overview. Drugs
Context 2018; 7: 212536.
[63]
Laino D., Mencaroni E., Esposito S.: Management of Pediatric Febrile
Seizures. Int J Environ Res Public Health 2018; 15: 2232.
[64]
García-Howard M., Herranz-Aguirre M., Moreno-Galarraga L. et al.: Case
Report: Benign Infantile Seizures Temporally Associated With COVID-19.
Front Pediatr 2020; 8: 507.
[65]
Chacón-Aguilar R., Osorio-Cámara J.M., Sanjurjo-Jimenez I. et al.:
COVID-19: Fever syndrome and neurological symptoms in a neonate. An
Pediatr 2020; 92: 373-374.
[66]
Chegondi M., Kothari H., Chacham S. et al.: Coronavirus Disease 2019
(COVID-19) Associated With Febrile Status Epilepticus in a Child. Cureus
2020; 12: 9840.
[67]
Agha R., Kojaoghlanian T., Avner J.R.: Initial Observations of COVID-19 in
US Children. Hosp Pediatr 2020; 10: 902-905.
[68]
Enner S., Hormozdyaran S., Varughese R. et al.: Central Apnea in an
Adolescent With COVID-19. Pediatr Neurol 2020; 110: 87-88.
[69]
Shahbaznejad L., Navaeifar M.R., Abbaskhanian A. et al.: Clinical
characteristics of 10 children with a pediatric inflammatory multisystem
syndrome associated with COVID-19 in Iran. BMC Pediatr 2020; 20: 513.
[70]
Bhatta S., Sayed A., Ranabhat B. et al.: New-Onset Seizure as the Only
Presentation in a Child With COVID-19. Cureus 2020; 12: 8820.
[71]
Farley M., Zuberi J.: COVID-19 Precipitating Status Epilepticus in
a Pediatric Patient. Am J Case Rep 2020; 21: e925776.
[72]
Dugue R., Cay-Martínez K.C., Thakur K.T. et al.: Neurologic manifestations
in an infant with COVID-19. Neurology 2020; 94: 1100-1102.
[73]
Garazzino S., Montagnani C., Donà D. et al.: Multicentre Italian study of
SARS-CoV-2 infection in children and adolescents. Euro Surveill 2020;
25: 2000600.
[74]
Granata T., Bisulli F., Arzimanoglou A. et al.: Did the COVID-19 pandemic
silence the needs of people with epilepsy? Epileptic Disord 2020; 22:
439-442.
[75]
Saeed A., Shorafa E.: Status epilepticus as a first presentation of
COVID-19 infection in a 3 years old boy. Case report and review the
literature. IDCases 2020; 22: 00942.
[76]
Lin J., Lawson E.C., Verma S. et al.: Cytotoxic Lesion of the Corpus Callosum
in an Adolescent with Multisystem Inflammatory Syndrome and SARS-
CoV-2 Infection. AJNR Am J Neuroradiol 2020;41: 2017-2019.
[77]
Gaur P., Dixon L., Jones B. et al.: COVID-19-Associated Cytotoxic Lesions
of the Corpus Callosum. AJNR Am J Neuroradiol 2020; 41: 1905-1907.
[78]
Abel D., Shen M.Y., Abid Z. et al: Encephalopathy and bilateral thalamic
lesions in a child with MIS-C associated with COVID-19. Neurology
2020; 95: 745-748.
[79]
Abdel-Mannan O., Eyre M., Löbel U. et al.: Neurologic and Radiographic
Findings Associated With COVID-19 Infection in Children. JAMA Neurol
2020; 77: 1–6.
[80]
Okarska-Napierała M., Ludwikowska K., Książyk J. et al.: Postępowanie
z dzieckiem z wieloukładowym zespołem zapalnym powiązanym
z COVID-19. Przegl Pediatr 2020; 49:1-9.
[81]
Elias M.D., McCrindle B.W., Larios G. et al.: Management of Multisystem
Inflammatory Syndrome in Children Associated With COVID-19:
A Survey From the International Kawasaki Disease Registry. CJC Open
2020; 2: 632-640.
[82]
De Paulis M., Oliveira D.B.L., Vieira R.P. et al.: Multisystem Inflammatory
Syndrome Associated With COVID-19 With Neurologic Manifestations
in a Child: A Brief Report. Pediatr Infect Dis J 2020; 39: 321-324.
[83]
Lad S.S., Kait S.P., Suryawanshi P.B. et al.: Neurological Manifestations
in Pediatric Inflammatory Multisystem Syndrome Temporally Associated
with SARS-CoV-2 (PIMS-TS). Indian J Pediatr 2020; 1-2.
[84]
Regev T., Antebi M., Eytan D. et al.: Pediatric Inflammatory Multisystem
Syndrome With Central Nervous System Involvement and
Hypocomplementemia Following SARS-COV-2 Infection. Pediatr Infect
Dis J 2020; 39: 206-207.
[85]
Lang P., Eichholz T., Bakchoul T. et al.: Defibrotide for the Treatment of
Pediatric Inflammatory Multisystem Syndrome Temporally Associated
With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2
Pediatric Patients. J Pediatric Infect Dis Soc 2020; 9: 622-625.
[86]
Zombori L., Bacon M., Wood H. et al.: Severe cortical damage associated
with COVID-19 case report. Seizure 2021; 84: 66-68.
[87]
Kabeerdoss J., Pilania R.K., Karkhele R. et al.: Severe COVID-19,
multisystem inflammatory syndrome in children, and Kawasaki disease:
immunological mechanisms, clinical manifestations and management.
Rheumatol Int 2021; 41: 19-32.
[88]
Dufort E.M., Koumans E.H., Chow E.J. et al.: Multisystem Inflammatory
Syndrome in Children in New York State. N Engl J Med 2020; 383: 347-
358.
[89]
Morris S.B., Schwartz N.G., Patel P. et al.: Case Series of Multisystem
Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection
- United Kingdom and United States, March-August 2020. MMWR Morb
Mortal Wkly Rep 2020; 69: 1450-1456.
[90]
Pouletty M., Borocco C., Ouldali N. et al.: Paediatric multisystem
inflammatory syndrome temporally associated with SARS-CoV-2
mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
Ann Rheum Dis 2020; 79: 999-1006.
Scholar Google
PubMed